You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KRAS mutations

Showing 1 - 25 of 2,952
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Cincinnati, Houston, Salt Lake City (YL-17231)

Not yet recruiting
  • Advanced Solid Tumors
  • Cincinnati, Ohio
  • +2 more
Oct 22, 2023

Lung Cancer, Gastro-intestinal Cancer Trial in Houston (Durvalumab, Adagrasib)

Not yet recruiting
  • Lung Cancer
  • Gastro-intestinal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
May 9, 2023

KRAS G12C Trial in Guangzhou (GFH925)

Recruiting
  • KRAS G12C
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Aug 1, 2022

Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer Trial in Denver, Nashville, Fairfax (MRTX0902, MRTX849)

Recruiting
  • Solid Tumor
  • +3 more
  • Denver, Colorado
  • +2 more
Dec 19, 2022

NSCLC Trial in Charleston (Sotorasib and Tarloxotinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Sotorasib and Tarloxotinib
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Mar 28, 2022

NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 17, 2023

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +3 more
  • Boston, Massachusetts
  • +9 more
Dec 22, 2022

Advanced NSCLC, KRAS Gene Mutation, Lung Cancer Trial in Switzerland (Binimetinib, Pemetrexed, Cisplatin)

Completed
  • Advanced Non-small Cell Lung Cancer
  • +2 more
  • Basel, Switzerland
  • +3 more
Jul 13, 2021

Associated With Colorectal Cancer

Not yet recruiting
  • Colorectal Neoplasms
  • Assessment of smoking ,heavy metal, organophosphorus exposure and d) Mutational analysis of the KRAS and BRAF genes:
  • (no location specified)
Dec 18, 2021

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Puerto Rico, United States (HBI-2376)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Duarte, California
  • +11 more
Aug 23, 2022

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

KRAS Gene Mutation, Metastatic Non-Squamous Non-Small Cell Lung Carcinoma, Recurrent Non-Squamous Non-Small Cell Lung Carcinoma

Active, not recruiting
  • KRAS Gene Mutation
  • +3 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Nov 1, 2021

Cancer Trial in Los Angeles (KRAS-variant and microRNA binding site mutation testing)

Recruiting
  • Cancer
  • KRAS-variant and microRNA binding site mutation testing
  • Los Angeles, California
    MiraKind
Aug 24, 2021

NSCLC, CRC, Solid Tumor Trial in Beijing (JAB-21822)

Recruiting
  • NSCLC
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 11, 2021

KRAS NP_004976.2:p.G12R, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in United

Completed
Has Results
  • KRAS NP_004976.2:p.G12R
  • +2 more
  • Laboratory Biomarker Analysis
  • Selumetinib Sulfate
  • Los Angeles, California
  • +8 more
Jan 20, 2021

Pancreatic Adenocarcinoma, Lung Cancer Trial in Truro (Biocartis Idylla platform - real time PCR detecting EGFR, KRAS and BRAF

Unknown status
  • Pancreatic Adenocarcinoma
  • Lung Cancer
  • Biocartis Idylla platform - real time PCR detecting EGFR, KRAS and BRAF mutations in liquid based cytology and blood plasma samples
  • Truro, Cornwall, United Kingdom
    Royal Cornwall Hospital
Feb 26, 2021

Each Codon-specific KRAS Mutation in Colorectal Cancer

Completed
  • Colorectal Cancer
  • Mutation
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Dec 10, 2022

Breast Cancer, Endometrial Cancer, Lung Cancer Trial (Serabelisib, Canagliflozin 300mg)

Unknown status
  • Breast Cancer
  • +4 more
  • (no location specified)
May 20, 2020

Infiltrating Urothelial Carcinoma, KRAS Gene Mutation Trial in France (Chemotherapy, Panitumumab)

Completed
  • Infiltrating Urothelial Carcinoma
  • KRAS Gene Mutation
  • Bordeaux, France
  • +16 more
Mar 4, 2021

Advanced Solid Tumor Trial in Beijing (YK0901 cells)

Not yet recruiting
  • Advanced Solid Tumor
  • YK0901 cells
  • Beijing, China
    Department of GI Oncology, Peking University Cancer Hospital
Jun 27, 2023

Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Odense

Recruiting
  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
    • Odense, Denmark
      Odense University Hospital
    Jun 5, 2022

    Pancreatic Cancer, Pancreatic Tumors, Pancreatic Ductal Adenocarcinoma Trial in Shanghai (Cyclophosphamide, Fludarabine, Mutant

    Recruiting
    • Pancreatic Cancer
    • +3 more
    • Shanghai, China
      Changhai Hospital
    Jun 13, 2022

    Pancreas Cyst Trial in Mannheim (Next Generation Sequencing, CEA and lipase, Cytology)

    Completed
    • Pancreas Cyst
    • Next Generation Sequencing
    • +3 more
    • Mannheim, Germany
      Tertiary referral hospital: Theresienkrankenhaus und St. Hedwig
    Dec 17, 2022

    Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma Recurrent Trial in Italy (Decitabine 50 MG [Dacogen])

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • Pancreatic Adenocarcinoma Recurrent
    • Decitabine 50 MG [Dacogen]
    • Milano, Italy
    • +5 more
    Jul 13, 2022

    Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy

    Active, not recruiting
    • Pancreas Adenocarcinoma
      • Goyang-si, Gyeonggi-do, Korea, Republic of
        NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
      Sep 27, 2022